CEGX closes $21 million Series B financing and appoints CEO
14 March 2016 | By Victoria White
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, has appointed Dr Geoff Smith as CEO...
List view / Grid view
News
A step towards the male contraceptive pill
13 March 2016 | By Victoria White
A group of researchers has taken a step toward a male contraceptive pill by tweaking some experimental compounds that show promise...
Collaboration to further explore the role of citrullinated proteins in cancer
11 March 2016 | By Victoria White
Scancell is to collaborate with the Karolinska Institutet to explore the scientific and clinical role of citrullinated proteins in the treatment of cancer...
Trioxacarcins synthesised as a potent anti-cancer agent
11 March 2016 | By Victoria White
Trioxacarcins disrupt the replication of cancer cells by binding and chemically modifying their genetic material...
Blood stem cells study could pave the way for leukaemia therapy
10 March 2016 | By Victoria White
Scientists are a step closer to creating blood stem cells that could reduce the need for bone marrow transplants in patients with cancer or blood disorders...
A molecule that could significantly reduce brain damage in stroke victims
10 March 2016 | By
This graphic depicts a new inhibitor, 6S, locking up an enzyme (red) to block the production of hydrogen sulfide (yellow and white). Hydrogen sulfide concentrations have been shown to climb after the onset of a stroke, leaving to brain damage. CREDIT: Matthew Beio, University of Nebraska-Lincoln Researchers have developed a…
Scientists identify genetic variations associated with bipolar disorder susceptibility
10 March 2016 | By Victoria White
The discovery, made by scientists at The Scripps Research Institute, may provide a target for new therapies for bipolar disorder...
Psaptides attack ovarian cancer on two fronts
10 March 2016 | By Victoria White
These findings from a new study suggest that psaptides could serve as a promising template for the development of treatment options directed against ovarian and maybe other cancers...
Research identifies first step in design of new anti-cancer drugs
10 March 2016 | By Victoria White
Researchers have identified a first step in the design of a new generation of anti-cancer drugs that include an agent to inhibit resistance to their effectiveness...
PhoreMost and The Wistar team up to identify targets in cancer, immunotherapy and aging
10 March 2016 | By Victoria White
PhoreMost has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system...
Ipsen and PeptiMimesis in oncology peptide partnership
10 March 2016 | By Victoria White
Ipsen and PeptiMimesis have signed a research partnership and a licensing option for the development and marketing of novel therapeutic peptides in oncology...
Injectible gel could be used to treat critical limb ischemia
9 March 2016 | By Victoria White
Critical limb ischemia causes extremely poor circulation in the limbs and leads to an estimated 230,000 amputations every year in North America and Europe...
Computer program predicts early-stage drug side effects
9 March 2016 | By Victoria White
Researchers from the University of Texas at San Antonio have developed the "in silico" testing system for drugs in the early stage of drug development...
New target identified for the treatment of asthma
8 March 2016 | By Victoria White
Researchers have identified that nociceptin has substantial activity in asthma models given before or during an asthma attack...
Collaboration to develop new treatments for tuberculosis
8 March 2016 | By Victoria White
Scientists at the Universities of Dundee and Cape Town are teaming up with Bayer to develop critically needed new treatments for tuberculosis...
